Ayala Pharmaceuticals, Inc. (ADXS)
OTCMKTS · Delayed Price · Currency is USD
0.0510
+0.0109 (27.18%)
At close: Dec 26, 2025
Ayala Pharmaceuticals Market Cap
Ayala Pharmaceuticals has a market cap or net worth of $2.51 million as of December 26, 2025. Its market cap has decreased by -89.69% in one year.
Market Cap
2.51M
Enterprise Value
n/a
Revenue
13.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since October 19, 2023, Ayala Pharmaceuticals's market cap has decreased from 9.68M to 2.51M, a decrease of -74.02%. That is a compound annual growth rate of -45.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 2.51M | 88.89% |
| Dec 31, 2024 | 1.33M | -83.23% |
| Dec 29, 2023 | 7.94M | -18.00% |
| Oct 19, 2023 | 9.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 724.00M |
| Elite Pharmaceuticals | 520.52M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 376.54M |
| CytoDyn | 353.44M |
| Nika Pharmaceuticals | 291.10M |
| Silence Therapeutics | 290.02M |